- Home
- SFBS vs LNTH Comparison
SFBS vs LNTH Comparison
Compare SFBS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SFBS | LNTH |
|---|---|---|
| Founded | 2005 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SFBS | LNTH |
|---|---|---|
| Price | $71.95 | $66.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $80.00 | $78.00 |
| AVG Volume (30 Days) | 294.9K | ★ 1.1M |
| Earning Date | 01-20-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | ★ 24.86 | N/A |
| EPS | ★ 4.67 | 2.39 |
| Revenue | $497,701,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $24.89 | $0.01 |
| Revenue Next Year | $17.02 | $0.52 |
| P/E Ratio | ★ $15.51 | $28.07 |
| Revenue Growth | ★ 16.24 | 1.95 |
| 52 Week Low | $66.48 | $47.25 |
| 52 Week High | $93.90 | $111.29 |
Technical Indicators
Market Signals| Indicator | SFBS | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 65.16 |
| Support Level | $72.53 | $66.20 |
| Resistance Level | $75.00 | $67.45 |
| Average True Range (ATR) | 1.78 | 1.71 |
| MACD | -0.20 | -0.08 |
| Stochastic Oscillator | 5.10 | 75.54 |
Price Performance
Historical ComparisonAbout SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.